HK Stock MarketDetailed Quotes
01830 PERFECT MEDICAL
- 2.600
- +0.010+0.39%
Not Open Nov 13 16:08 CST
3.27BMarket Cap10.36P/E (TTM)
2.610High2.500Low525.31KVolume2.570Open2.590Pre Close1.35MTurnover0.04%Turnover Ratio10.36P/E (Static)1.26BShares3.63552wk High6.57P/B3.27BFloat Cap2.09752wk Low0.32Dividend TTM1.26BShs Float9.787Historical High0.315Dividend LFY4.25%Amplitude-2.322Historical Low2.560Avg Price1000Lot Size12.12%Div YieldTTM12.12%Div Yield LFY
PERFECT MEDICAL Key Stats
All
YOY
| (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | (Q6)Sep 30, 2020 | (FY)Mar 31, 2020 | (Q6)Sep 30, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | -1.98%383.72M | ---- | 3.52%391.46M | ---- | 5.58%378.15M | ---- | -20.51%358.16M | ---- | 11.51%450.58M | ---- |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | -58.76%-12.57M | ---- | -352.80%-7.92M | ---- | 67.70%-1.75M | ---- | 13.84%-5.41M | ---- | -49.73%-6.28M | ---- |
| Interest expense - adjustment | -10.37%11.22M | ---- | -22.20%12.52M | ---- | 22.47%16.1M | ---- | 10.47%13.14M | ---- | --11.9M | ---- |
| Dividend (income)- adjustment | 33.85%-1.97M | ---- | 4.85%-2.98M | ---- | -21.88%-3.14M | ---- | -19.56%-2.57M | ---- | ---2.15M | ---- |
| Impairment and provisions: | 2,130.12%1.85M | ---- | -87.48%83K | ---- | 204.08%663K | ---- | -374.57%-637K | ---- | -80.75%232K | ---- |
| -Other impairments and provisions | 2,130.12%1.85M | ---- | -87.48%83K | ---- | 204.08%663K | ---- | -374.57%-637K | ---- | -80.75%232K | ---- |
| Revaluation surplus: | ---- | ---- | ---- | ---- | 315.19%3.05M | ---- | -183.58%-1.42M | ---- | 1,326.81%1.69M | ---- |
| -Other fair value changes | ---- | ---- | ---- | ---- | 315.19%3.05M | ---- | -183.58%-1.42M | ---- | 1,326.81%1.69M | ---- |
| Asset sale loss (gain): | -57.55%467K | ---- | 920.90%1.1M | ---- | -128.57%-134K | ---- | -67.85%469K | ---- | 157.06%1.46M | ---- |
| -Loss (gain) on sale of property, machinery and equipment | -57.55%467K | ---- | 920.90%1.1M | ---- | -128.57%-134K | ---- | -67.85%469K | ---- | 157.06%1.46M | ---- |
| Depreciation and amortization: | -9.67%201.96M | ---- | 2.08%223.59M | ---- | 27.91%219.05M | ---- | 10.61%171.26M | ---- | 119.95%154.82M | ---- |
| Special items | -65.16%1.3M | ---- | -18.26%3.74M | ---- | 49.30%4.58M | ---- | 202.47%3.07M | ---- | -67.78%1.01M | ---- |
| Operating profit before the change of operating capital | -5.73%585.99M | ---- | 0.82%621.6M | ---- | 15.02%616.57M | ---- | -12.59%536.06M | ---- | 29.96%613.27M | ---- |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | 181.13%2.46M | ---- | 1.04%-3.04M | ---- | -205.58%-3.07M | ---- | -217.43%-1M | ---- | 232.97%855K | ---- |
| Accounts receivable (increase)decrease | -57.26%-37.28M | ---- | -151.76%-23.7M | ---- | 621.58%45.8M | ---- | -110.98%-8.78M | ---- | 3,550.48%79.98M | ---- |
| Accounts payable increase (decrease) | -42.06%10.04M | ---- | 150.54%17.33M | ---- | -601.29%-34.29M | ---- | 340.29%6.84M | ---- | 1.76%-2.85M | ---- |
| Special items for working capital changes | ---- | ---- | ---- | ---- | -155.22%-82.62M | ---- | 232.57%149.61M | ---- | 13.68%44.99M | ---- |
| Cash from business operations | -9.77%570.92M | ---- | 16.66%632.71M | ---- | -20.56%542.38M | ---- | -7.27%682.73M | ---- | 44.32%736.24M | ---- |
| Other taxs | -7.87%-86.36M | ---- | -164.83%-80.06M | ---- | 66.64%-30.23M | ---- | 7.66%-90.63M | ---- | -61.42%-98.14M | ---- |
| Interest received - operating | 58.76%12.57M | ---- | 352.80%7.92M | ---- | -69.66%1.75M | ---- | -7.91%5.76M | ---- | 53.21%6.26M | ---- |
| Special items of business | ---- | -3.62%288.02M | ---- | -16.84%298.83M | ---- | 5.21%359.35M | ---- | 1.47%341.55M | ---- | 49.72%336.61M |
| Net cash from operations | -11.32%497.12M | -3.62%288.02M | 9.08%560.57M | -16.84%298.83M | -14.04%513.9M | 5.21%359.35M | -7.22%597.86M | 1.47%341.55M | 42.11%644.36M | 49.72%336.61M |
| Cash flow from investment activities | ||||||||||
| Dividend received - investment | 36.61%1.97M | ---- | -28.47%1.45M | ---- | -21.49%2.02M | ---- | 19.56%2.57M | ---- | --2.15M | ---- |
| Decrease in deposits (increase) | 200.10%210.22M | ---- | ---210M | ---- | ---- | ---- | 586.26%70.9M | ---- | -208.86%-14.58M | ---- |
| Sale of fixed assets | -39.27%150K | ---- | -84.55%247K | ---- | -15.71%1.6M | ---- | -52.52%1.9M | ---- | -77.15%4M | ---- |
| Purchase of fixed assets | -102.61%-54.18M | ---- | 81.50%-26.74M | ---- | -84.79%-144.55M | ---- | 18.89%-78.22M | ---- | -81.36%-96.44M | ---- |
| Recovery of cash from investments | -47.79%8.51M | ---- | -95.77%16.3M | ---- | -9.52%385.38M | ---- | 249.30%425.95M | ---- | 4,315.10%121.95M | ---- |
| Cash on investment | -78.06%-4.11M | ---- | 99.02%-2.31M | ---- | 67.51%-234.37M | ---- | -700.25%-721.34M | ---- | -19.87%-90.14M | ---- |
| Other items in the investment business | ---- | 368.83%188.29M | ---- | 42.43%-70.04M | ---- | -582.76%-121.65M | ---- | -961.23%-17.82M | ---- | 91.50%-1.68M |
| Net cash from investment operations | 173.54%162.56M | 368.83%188.29M | -2,294.38%-221.06M | 42.43%-70.04M | 103.38%10.07M | -582.76%-121.65M | -308.19%-298.25M | -961.23%-17.82M | 22.87%-73.07M | 91.50%-1.68M |
| Net cash before financing | 94.31%659.69M | 108.19%476.32M | -35.20%339.51M | -3.75%228.79M | 74.88%523.97M | -26.58%237.7M | -47.55%299.62M | -3.34%323.73M | 59.27%571.29M | 63.33%334.93M |
| Cash flow from financing activities | ||||||||||
| Issuing shares | ---- | ---- | -0.01%15M | ---- | 0.07%15M | ---- | -49.98%14.99M | ---- | 49.95%29.96M | ---- |
| Interest paid - financing | 10.37%-11.22M | ---- | 22.20%-12.52M | ---- | -22.47%-16.1M | ---- | -10.47%-13.14M | ---- | ---11.9M | ---- |
| Dividends paid - financing | -104.36%-391.93M | ---- | 52.70%-191.79M | ---- | -43.65%-405.48M | ---- | -29.03%-282.27M | ---- | 33.12%-218.77M | ---- |
| Absorb investment income | --4.7M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Issuance expenses and redemption of securities expenses | 86.10%-1.39M | ---- | 53.72%-10.03M | ---- | -382.69%-21.67M | ---- | 89.30%-4.49M | ---- | ---41.96M | ---- |
| Other items of the financing business | ---- | -195.09%-278.4M | ---- | -16.78%-94.34M | ---- | -87.44%-80.79M | ---- | 77.17%-43.1M | ---- | -28.53%-188.8M |
| Net cash from financing operations | -55.51%-520.97M | -195.09%-278.4M | 40.81%-335.02M | -16.78%-94.34M | -43.50%-565.97M | -87.44%-80.79M | -19.35%-394.41M | 77.17%-43.1M | -7.59%-330.45M | -28.53%-188.8M |
| Effect of rate | -6.22%-10.51M | 5.03%-12.59M | -212.02%-9.89M | -145.21%-13.26M | -115.12%-3.17M | -182.05%-5.41M | 231.82%20.98M | 136.12%6.59M | -29.57%-15.92M | -198.80%-18.25M |
| Net Cash | 2,990.84%138.72M | 47.21%197.92M | 110.68%4.49M | -14.31%134.45M | 55.69%-42M | -44.09%156.91M | -139.36%-94.8M | 92.05%280.63M | 367.25%240.84M | 151.19%146.13M |
| Begining period cash | -1.22%439.19M | -1.22%439.19M | -9.22%444.6M | -9.22%444.6M | -13.10%489.77M | -13.10%489.77M | 66.41%563.59M | 66.41%563.59M | 13.11%338.67M | 13.11%338.67M |
| Cash at the end | 29.19%567.4M | 10.38%624.51M | -1.22%439.19M | -11.77%565.78M | -9.22%444.6M | -24.63%641.27M | -13.10%489.77M | 82.36%850.81M | 66.41%563.59M | 32.74%466.55M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
% Chg
No Data